Successful Proof of Concept

Open PDF
Stock Singular Health Group Ltd (SHG.ASX)
Release Time 17 Jan 2025, 8:50 a.m.
Price Sensitive Yes
 Singular Health Achieves Proof of Concept with PNS
Key Points
  • Successful demonstration of technical proof of concept with PNS
  • Medical images searched, retrieved, shared, and analysed by AI in minutes
  • Audit trail and use of third-party AI model for quantitative image analysis
Full Summary

Singular Health (ASX: SHG) has announced the successful completion of the technical proof of concept (Phase 1) of its Memorandum of Understanding (MOU) with Provider Network Solutions (PNS), a Miami-based Managed Service Organisation (MSO). The proof of concept demonstrated the ability of Singular Health's Medical File Transfer Protocol (MFTP) to search, retrieve, share, and analyze medical images from multiple remote facilities in minutes, as opposed to hours or days by manual processes. The demonstration also showcased the use of a third-party AI model to provide quantitative analysis of medical images and generate reports without adding to radiologists' workload, as well as the implementation of an audit trail. As a result of the successful Phase 1, Singular Health and PNS are now moving into Phase 2 of the MOU, which will focus on detailed planning and budgeting for the initiative, scheduled for execution in the March quarter of 2025 (Q3 FY25). This will provide further momentum as the companies progress towards Phase 3, the commencement of the commercial pilot. Singular Health's Managing Director and CEO, Denning Chong, expressed excitement about the opportunity to implement the MFTP solution throughout the PNS network and the wider MSO network, while PNS CEO, Dr. Jose Pelayo, highlighted the potential for significant cost savings associated with the reduction of duplicate medical imaging within PNS and the broader MSO network.

Outlook

Singular Health and PNS are moving into Phase 2 of the MOU, which will focus on detailed planning and budgeting for the initiative, scheduled for execution in the March quarter of 2025 (Q3 FY25). This will provide further momentum as the companies progress towards Phase 3, the commencement of the commercial pilot.